Simply Biotic Probiotic blog image

Clostridium difficile (C. Diff) is a serious gut infection (leads to diarrhea, abdominal pain, lethargy, malnutrition, kidney injury and even death) that results mostly from the use of antibiotics. It is caused by disruption of healthy gut bacteria. It is a life threatening infection requiring intensive and costly treatment. It is a highly contagious disease and spreads easily with contact.

A recent study published in June issue of prestigious Gastroenterology Journal by Cornell University authors - demonstrates the protective effect of probiotics to prevent C. Diff infections when started within 2 days of first antibiotic dose. In the study there was a reduction of 60% infection rate in patients on probiotics.

The probiotic formulas which were effective contained lactobacillus, Saccharomyces, Bifidobacterium, and Streptococcus, either alone or in combination. Probiotics did not result in any adverse events or side effects.

Both our formulations - Simply Biotic and Simply Biotic Plus contain 10 unique bacterial strains which includes strains of lactobacillus and Streptococcus shown to prevent C. Diff. infection. While formulating our probiotic, we chose multiple strains of bacteria to provide the maximum health benefits to our patients.

We have achieved the highest quality and an affordable product. SImply Biotic probiotics are almost half the cost compared to some of the other probiotics with comparable formulations. We are positioning ourselves to provide the best probiotic to the people with a reasonable cost. It is not a hidden fact that every business has to make money to survive, but we want to do it the right way by selling a high quality product with a smaller margin of profit to keep the cost low for our consumers.

Given the magnitude of benefit and savings that can be accomplished by timely use of probiotics, I expect use of quality probiotics with antibiotics would become a standard of care in the future. May be a simple and cost effective approach to curb the menace of C. Diff. has finally arrived, but surely we need a robust clinical trial to prove its final merit beyond doubt.

Dr. Adi Malhotra
Founder, Simply Biotic